Drug intelligence / Profile preview

Zicam Cold Remedy Nasal Spray

Development stage
Unknown
Lead developer
Matrixx Initiatives
Administration
Intranasal
01

Overview

Zicam Cold Remedy Nasal Spray is a homeopathic intranasal product marketed for the reduction of common cold duration and the relief of nasal congestion. Developed by Zicam (a brand owned by Church & Dwight), the current 'no-drip' formulation is zinc-free and plant-based, utilizing active ingredients such as *Galphimia glauca*, *Luffa operculata*, and *Sabadilla*. This formulation was established following the 2009 FDA warning regarding permanent anosmia (loss of smell) linked to previous zinc-gluconate-based Zicam nasal sprays. As a homeopathic remedy, it is prepared according to the Homeopathic Pharmacopoeia of the United States (HPUS) and is classified as an unapproved homeopathic drug. It is intended for use at the first sign of a cold and often includes inactive ingredients like menthol and eucalyptus for a cooling sensation.

Brand names
Zicam Cold Remedy Nasal SprayZicam Nasal Spray
Other names
Zicam Homeopathic Nasal Spray

Beyond the preview

Go deeper on Zicam Cold Remedy Nasal Spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zicam Cold Remedy Nasal Spray.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call